Home
Kevin Charles Gorman, Director: Neurocrine Biosciences NBIX Sell · Filed 25/02/14
Trade details
- Type
- Insider sale
- Amount
- $351,440.16
- Shares · price
- 3,012 sh · $116.68 a share
- Held after
- 524,209 sh
- Trade date
- 25/02/13
- Filed
- 25/02/14
- Days to filing
- 1 days
Sold 0.6% of holdings
- Share of holding sold
- 0.6%
Neurocrine Biosciences trades, last 26 weeks
What else happened in Neurocrine Biosciences around then
Filed or reported within 30 days of the trade day · 25/01/14~25/03/15Kevin Charles Gorman's recent trades
- Kevin Charles Gorman
Sell10b5-1 planXencor
Sell10b5-1 planXencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/17
Traded 06/15
- Kevin Charles Gorman
Planned sale10b5-1 planXencor
Planned sale10b5-1 planXencor
XNCR
$92.7K
7,527 sh
$92.7K
Filed 06/15
Traded 06/15
- Kevin Charles Gorman
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 planNeurocrine Biosciences
NBIX
$37.8M
245,088 sh
$37.8M
Filed 05/21
Traded 05/19
- Kevin Charles Gorman
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 planNeurocrine Biosciences
NBIX
$38.5M
245,088 sh
$38.5M
Filed 05/19
Traded 05/19
- Kevin Charles Gorman
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 planNeurocrine Biosciences
NBIX
$13.4M
106,322 sh
$13.4M
Filed 25/08/11
Traded 25/08/07
